Title : CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk.

Pub. Date : 2002 Apr

PMID : 11927498






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 CYP2A6 activity determined by caffeine phenotyping: association with colorectal cancer risk. Caffeine cytochrome P450 family 2 subfamily A member 6 Homo sapiens
2 CYP2A6 phenotype was determined using caffeine as a probe drug in individuals participating in a case-control study of colorectal cancer (127 cases and 333 controls matched on age, gender, race, and geographic region). Caffeine cytochrome P450 family 2 subfamily A member 6 Homo sapiens
3 Conversion of the caffeine metabolite 1,7-dimethylxanthine (17X) to 1,7-dimethyl uric acid (17U) is catalyzed primarily by CYP2A6, and this activity can be assayed by comparison of urinary molar ratios of metabolites. Caffeine cytochrome P450 family 2 subfamily A member 6 Homo sapiens
4 We found a strong relationship between CYP2A6 activity, measured by urinary caffeine metabolite ratio, and colorectal cancer risk. Caffeine cytochrome P450 family 2 subfamily A member 6 Homo sapiens